Cargando…

Prognostic Implication of the Expression Level of PECAM-1 in Non-small Cell Lung Cancer

Background: Lung cancer is a malignant disease that threatens human health. Hence, it is crucial to identify effective prognostic factors and treatment targets. Single-cell RNA sequencing can quantify the expression profiles of transcripts in individual cells. Methods: GSE117570 profiles were downlo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Shuhui, Wang, Yue, Li, Jingwen, Ling, Xuxinyi, Zhang, Yao, Zhou, Yan, Zhong, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019905/ https://www.ncbi.nlm.nih.gov/pubmed/33828969 http://dx.doi.org/10.3389/fonc.2021.587744

Ejemplares similares

Tumor genomics and response to chemotherapy in advanced non-small cell lung cancer with exon 20 insertion epidermal growth factor receptor mutations
por: Wang, Yue, et al.
Publicado: (2020)

A nomogram model for predicting the risk of checkpoint inhibitor‐related pneumonitis for patients with advanced non‐small‐cell lung cancer
por: Zhang, Yao, et al.
Publicado: (2023)

The genomic characteristics of different progression patterns in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
por: Li, Jingwen, et al.
Publicado: (2021)

A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells
por: Cao, Shuhui, et al.
Publicado: (2022)

Clinical value of an electromagnetic navigation system for CT-guided percutaneous lung biopsy of peripheral lung lesions
por: Zhang, Yao, et al.
Publicado: (2021)

Development of a Survival Prognostic Model for Non-small Cell Lung Cancer
por: Zhang, Yue-Hua, et al.
Publicado: (2020)

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer
por: Daniello, Lea, et al.
Publicado: (2021)

A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer
por: Cao, Shuhui, et al.
Publicado: (2022)

Development of a tRNA-Derived Small RNA Prognostic Panel and Their Potential Functions in Osteosarcoma
por: Tang, Zhenming, et al.
Publicado: (2021)

Comprehensive Analysis of Immune Implication and Prognostic Value of IFI44L in Non-Small Cell Lung Cancer
por: Zeng, Yong, et al.
Publicado: (2022)

Editorial: Prognostic factors in non-small cell lung cancer
por: Rahouma, Mohamed, et al.
Publicado: (2023)

PECAM-1 senses the pressure
por: LeBrasseur, Nicole
Publicado: (2002)

Influence of PECAM‐1 ligand interactions on PECAM‐1‐dependent cell motility and filopodia extension
por: Abraham, Valsamma, et al.
Publicado: (2016)

Prognostic implications of prostaglandin E-major urinary metabolite in resected non-small-cell lung cancer
por: Mikubo, Masashi, et al.
Publicado: (2023)

Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity
por: Qi, Jing, et al.
Publicado: (2022)

CDK7 is a prognostic biomarker for non-small cell lung cancer
por: Kuempers, Christiane, et al.
Publicado: (2022)

Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer
por: Boscolo, Alice, et al.
Publicado: (2020)

Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer
por: Su, Dan, et al.
Publicado: (2021)

Construction and validation of a nomogram of risk factors for new-onset atrial fibrillation in advanced lung cancer patients after non-surgical therapy
por: Chen, Jindong, et al.
Publicado: (2023)

The Resistance Mechanisms and Treatment Strategies for ALK-Rearranged Non-Small Cell Lung Cancer
por: Pan, Yue, et al.
Publicado: (2021)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer
por: Zeng, Yangyang, et al.
Publicado: (2021)

The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
por: Chen, Haiqing, et al.
Publicado: (2021)

Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer
por: Zhu, Jinhong, et al.
Publicado: (2020)

PECAM-1 is required for transendothelial migration of leukocytes
Publicado: (1993)

Haemodynamics Regulate Fibronectin Assembly via PECAM
por: Chen, Zhongming, et al.
Publicado: (2017)

Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer
por: Li, Qiaxuan, et al.
Publicado: (2021)

Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer
por: Jiang, Jun, et al.
Publicado: (2021)

Prognostic Role of Soluble Programmed Death Ligand 1 in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Liao, Guixiang, et al.
Publicado: (2021)

Involvement of TIMP-1 in PECAM-1-mediated tumor dissemination
por: Abraham, Valsamma, et al.
Publicado: (2018)

A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer
por: He, Ru, et al.
Publicado: (2019)

WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer
por: Li, Zheng, et al.
Publicado: (2022)

Predictive power of deep-learning segmentation based prognostication model in non-small cell lung cancer
por: Gainey, Jordan C., et al.
Publicado: (2023)

Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer
por: Wang, Wenxian, et al.
Publicado: (2020)

Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients
por: Li, Hang, et al.
Publicado: (2021)

Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
por: Peng, Yurong, et al.
Publicado: (2023)

The Prognostic Role of MET Protein Expression Among Surgically Resected Non-small Cell Lung Cancer Patients: A Meta-Analysis
por: Ma, Guangzhi, et al.
Publicado: (2019)

Prognostic Implication of Energy Metabolism-Related Gene Signatures in Lung Adenocarcinoma
por: Mu, Teng, et al.
Publicado: (2022)

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients
por: Pankova, Olga V., et al.
Publicado: (2021)

A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population
por: Wang, Lijie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p01nr69201se8n62eqe1pqcca7